Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase.
J Pharmacol Exp Ther. 2023 Mar;384(3):429-438. doi: 10.1124/jpet.122.001401. Epub 2023 Jan 10.
J Pharmacol Exp Ther. 2023.
PMID: 36627205
Free PMC article.
Deletion of PTP4A3 phosphatase in high grade serous ovarian cancer cells decreases tumorigenicity and produces marked changes in intracellular signaling pathways and cytokine release.
Lazo JS, Isbell KN, Vasa SA, Llaneza DC, Mingledorff GA, Sharlow ER.
Lazo JS, et al. Among authors: vasa sa.
J Pharmacol Exp Ther. 2024 Apr 5:JPET-AR-2024-002110. doi: 10.1124/jpet.124.002110. Online ahead of print.
J Pharmacol Exp Ther. 2024.
PMID: 38580450
Free article.
Item in Clipboard
Cite
Cite